Vasoactive intestinal peptide rescues cultured rat myenteric neurons from lipopolysaccharide induced cell death

被引:59
作者
Arciszewski, Marcin B. [2 ]
Sand, Elin [1 ]
Ekblad, Eva [1 ]
机构
[1] Lund Univ, Dept Expt Med Sci, Unit Neurogastroenterol, SE-22184 Lund, Sweden
[2] Univ Agr, Dept Anim Anat & Histol, Lublin, Poland
关键词
myenteric neurons; lipopolysaccharide; vasoactive intestinal peptide; enteric nervous system; inflammatory bowel disease; irritable bowel syndrome;
D O I
10.1016/j.regpep.2007.09.021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The role of the enteric nervous system in intestinal inflammation is not fully understood and the plethora of cellular activities concurrently ongoing in vivo renders intelligible studies difficult. In order to explore possible effects of bacterial lipopolysaccharide (LPS) on enteric neurons we utilised cultured myenteric neurons from rat small intestine. Exposure to LPS caused markedly reduced neuronal survival and increased neuronal expression of vasoactive intestinal peptide (VIP), while the expression of Toll-like receptor 4 (TLR4) was unchanged. TLR4 was expressed in approximately 35% of all myenteric neurons irrespective of if they were cultured in the presence or absence of LPS. In neurons cultured in medium, without LPS, 50% of all TLR4-immunoreactive neurons contained also VIP. Addition of LPS to the neuronal cultures markedly increased the proportion of TLR4-immunoreactive neurons also expressing VIP, while the proportion of TLR4 neurons devoid of VIP decreased. Simultaneous addition of LPS and VIP to the neuronal cultures resulted in a neuronal survival comparable to controls. Conclusions: LPS recognition by myenteric neurons is mediated via TLR4 and causes neuronal cell death. Presence of VIP rescues the neurons from LPS-induced neurodegeneration. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:218 / 223
页数:6
相关论文
共 38 条
  • [1] Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease
    Abad, C
    Martinez, C
    Juarranz, MG
    Arranz, A
    Leceta, J
    Delgado, M
    Gomariz, RP
    [J]. GASTROENTEROLOGY, 2003, 124 (04) : 961 - 971
  • [2] β-adrenergic receptor agonists and antagonists counteract LPS-induced neuronal death in retinal cultures by different mechanisms
    Arai, K
    Wood, JPM
    Osborne, NN
    [J]. BRAIN RESEARCH, 2003, 985 (02) : 176 - 186
  • [3] Lipopolysaccharide induces cell death in cultured porcine myenteric neurons
    Arciszewski, M
    Pierzynowski, S
    Ekblad, E
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (09) : 1661 - 1668
  • [4] Effects of vasoactive intestinal peptide and galanin on survival of cultured porcine myenteric neurons
    Arciszewski, MB
    Ekblad, E
    [J]. REGULATORY PEPTIDES, 2005, 125 (1-3) : 185 - 192
  • [5] Neurochemical coding in the small intestine of patients with Crohn's disease
    Belai, A
    Boulos, PB
    Robson, T
    Burnstock, G
    [J]. GUT, 1997, 40 (06) : 767 - 774
  • [6] Is irritable bowel syndrome a low-grade inflammatory bowel disease?
    Bercik, P
    Verdu, EF
    Collins, SM
    [J]. GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2005, 34 (02) : 235 - +
  • [7] Myenteric plexus injury and apoptosis in experimental colitis
    Boyer, L
    Ghoreishi, M
    Templeman, V
    Vallance, BA
    Buchan, AM
    Jevon, G
    Jacobson, K
    [J]. AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, 2005, 117 (01): : 41 - 53
  • [8] Intestinal epithelial TOLLerance versus inTOLLerance of commensals
    Cario, E
    Podolsky, DK
    [J]. MOLECULAR IMMUNOLOGY, 2005, 42 (08) : 887 - 893
  • [9] Toll-like receptor signaling and its relevance to intestinal inflammation
    Cario, Elke
    Podolsky, Daniel K.
    [J]. INFLAMMATORY BOWEL DISEASE: GENETICS, BARRIER FUNCTION, IMMUNOLOGIC MECHANISMS, AND MICROBIAL PATHWAYS, 2006, 1072 : 332 - 338
  • [10] Signaling mechanisms of vasoactive intestinal peptide in inflammatory conditions
    Chorny, Alejo
    Gonzalez-Rey, Elena
    Varela, Niveves
    Robledo, Gerna
    Delgado, Mario
    [J]. REGULATORY PEPTIDES, 2006, 137 (1-2) : 67 - 74